// App-Quantinova.ai

Sa1195 : Patient Reported Outcome Measures Derived From the Crohn's Disease Activity Index: Correlation Between PRO2 and PRO3 Scores and CDAI-Defined Clinical Thresholds

Researchers

Presenter

  • Geert R. -Haens

Principal Investigators

  • Brian G. Feagan

  • William Sandborn

  • Margaret K. Vandervoort

  • Guangyong Zou

  • Robert L. Rolleri

  • Craig Paterson

  • William P. Forbes

  • Enoch Bortey

  • Barrett G. Levesque

Medical Centers

  • Academic Medical Centre, Amsterdam, Belgium

  • Department of Surgery, Western University, London, ON, Canada

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

  • Canada

  • Belgium

Companies

  • Salix Pharmaceutical

  • Robarts Clinical Tri

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Crohn's disease

Biomarkers

  • N/A

Drug/Treatment

  • Methotrexate

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved